Table 5 Summary of TE-ADEs by SOC and PT for Safety Population (N = 162) Adolescent
From: Two single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD
All Subjects (N = 162) | ||
|---|---|---|
n (%) | Events | |
Any TE-ADE | 4 (2.5%) | 4 |
Nervous system disorders | 1 (0.6%) | 1 |
Headache | 1 (0.6%) | 1 |
Psychiatric disorders | 3 (1.9%) | 3 |
Frustration tolerance decreased | 3 (1.9%) | 3 |
